hiw are patients screened for glp-1 drugs in colorado Study: 40% of Never Fill Their Prescriptions GLP-1 Medication & Surrogacy: Can

Biotech company CervoMed presented new data indicating that its oral neflamapimod treatment for dementia with Lewy bodies led to a significant reduction in widely used neurodegeneration biomarkers , including plasma glial fibrillary acidic protein and beta amyloid 42/40 ratio

Meanwhile, oral semaglutide has shown cardiovascular safety, with outcome data continuing to evolve

Douros, A

Most studies have shown that many people who stop using the GLP-1 drugs regain weight they lost while taking them

By mining and analyzing the FAERS database, this study addressed concerns about the potential association between GLP-1RAs and SSIBs and helped dispel public concerns regarding drug safety

The need for better breast cancer prevention strategies GLP-1 medications are highly effective at helping people lose weight, and maintaining a healthy weight has long been recommended as part of breast cancer prevention strategies because being overweight or obese, particularly after menopause, is a known risk factor for breast cancer